Feasibility and effectiveness of curative embolization of cerebral arteriovenous malformations

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042414

Enrollment

Unknown

Registered

2021-01-21

Start date

2021-01-20

Completion date

Unknown

Last updated

2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral arteriovenous malformations

Interventions

A:Curative embolism

B:Supporting embolism

Eligibility

Sex/Gender

All

Age

No minimum to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients with cerebral arteriovenous malformation confirmed by imaging; (2) Informed consent signed by the patient or his (her) legal guardian.

Exclusion criteria

Exclusion criteria: (1) Patients with a history of treatment of cerebral arteriovenous malformation; (2) With history of cerebral hemorrhage; (3) Pregnant or lactating women; (4) There are contraindications related to cerebral angiography, anesthesia or operation.

Design outcomes

Primary

Measure	Time frame
The occlusion rate of nidus at immediate and 2-year follow-up after operation;The mRS score was 3 months after operation;	—

Secondary

Measure	Time frame
Cerebrovascular events occurred after operation and two years follow-up;	—

Countries

China

Contacts

Public ContactLi Guilin

Xuanwu Hospital, Capital Medical University

lgl723@sina.com+86 13901056074

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026